Fertility of male survivors of childhood cancer: A report from the Childhood Cancer Survivor Study Journal Article


Authors: Green, D. M.; Kawashima, T.; Stovall, M.; Leisenring, W.; Sklar, C. A.; Mertens, A. C.; Donaldson, S. S.; Byrne, J.; Robison, L. L.
Article Title: Fertility of male survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
Abstract: Purpose This study was undertaken to determine the effect of treatment for childhood cancer on male fertility. Patients and Methods We reviewed the fertility of male Childhood Cancer Survivor Study survivor and sibling cohorts who completed a questionnaire. We abstracted the chemotherapeutic agents administered, the cumulative dose of drug administered for selected drugs, and the doses and volumes of all radiation therapy from medical records. Risk factors for siring a pregnancy were evaluated using Cox proportional hazards models. Results The 6,224 survivors age 15 to 44 years who were not surgically sterile were less likely to sire a pregnancy than siblings (hazard ratio [HR], 0.56; 95% CI, -0.49 to 0.63). Among survivors, the HR of siring a pregnancy was decreased by radiation therapy of more than 7.5 Gy to the testes (HR, 0.12; 95% CI, -0.02 to 0.64), higher cumulative alkylating agent dose (AAD) score or treatment with cyclophosphamide (third tertile HR, 0.42; 95% CI, -0.31 to 0.57) or procarbazine (second tertile HR, 0.48; 95% CI, -0.26 to 0.87; third tertile HR, 0.17; 95% CI, -0.07 to 0.41). Compared with siblings, the HR for ever siring a pregnancy for survivors who had an AAD score = 0, a hypothalamic/pituitary radiation dose = 0 Gy, and a testes radiation dose = 0 Gy was 0.91 (95% CI, 0.73 to 1.14; P = .41). Conclusion This large study identified risk factors for decreased fertility that may be used for counseling male cancer patients.
Keywords: chemotherapy; combination chemotherapy; long-term survivors; acute lymphoblastic-leukemia; gonadal-function; testicular function; function following; advanced hodgkins-disease; boys following treatment; leydig-cell function; cyclophosphamide therapy
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 2
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-01-10
Start Page: 332
End Page: 339
Language: English
ACCESSION: ISI:000273418000025
DOI: 10.1200/jco.2009.24.9037
PROVIDER: wos
PMCID: PMC2815721
PUBMED: 19949008
Notes: --- - Article - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Charles A Sklar
    322 Sklar